Teva Stock Is Rising on Reports of an Opioid Settlement | Barron's
Teva Pharmaceuticals Soars After Buffett's Berkshire Hathaway Discloses Stake
Teva shares plunge as competitors get nod for copycat flagship drug | The Times of Israel
Teva CEO Schultz likely won't renew employment contract: reports
Teva Pharmaceutical Industries (TEVA) Stock Price, News & Info | The Motley Fool
Teva Pharmaceuticals (@TevaUSA) / Twitter
TEVA News Today | Why did Teva Pharmaceutical Industries stock go down today?
Teva Pharm expects to start paying U.S. opioid settlement in 2023 - CEO
Teva sees return to growth after opioid settlement, shares jump | Reuters
Teva Pharmaceutical's Sales Slump 18% - WSJ
Teva Pharmaceuticals found liable in New York opioid trial - BBC News
Teva Stock Soars After Reaching $4.25 Billion Opioid Settlement | Barron's
Teva Pharmaceuticals is found liable in the opioid crisis : NPR
Earnings Preview: It's a mixed bag for Teva Pharma in Q3 | AlphaStreet
Teva Pharmaceutical Industries' new CEO Jeremy Levin speaks during a news conference in Tel Aviv May 9, 2012. Teva Pharmaceutical Industries posted a 40 percent jump in quarterly profit that beat estimates,
Marksans Pharma acquires Teva's manufacturing site in Goa - The Economic Times
Teva 'Plagued By Problems,' Downgraded On Lost MS Drug Patents, DOJ Probe | Stock News & Stock Market Analysis - IBD
Teva CEO: Company Would Have Gone Bankrupt Without Layoffs - Business - Haaretz.com
New York could get $524M under opioid settlements with Teva - ABC News
Allergan to own 10% stake in Teva
Teva Pharmaceuticals to pay New York $523 million to settle claims from its role in opioids crisis - ABC News
TEVA: Can Teva Pharmaceutical Stock Continue to Rebound in 2021?
Teva Pharmaceutical Rallies, So Let's Adjust Our Bullish Strategy - RealMoney
Teva proposes settlement in US opioid lawsuits | Israel National News - Arutz Sheva
Jury finds Teva Pharmaceuticals fueled opioid epidemic in New York State
teva News and latest stories | The Jerusalem Post
